COLOSSUS
COLOSSUS is a 14-partner H2020 Research and Innovation action (H2020-SC1-2017-Two-Stage-RTD) funded under “Understanding health, wellbeing and disease” coordinated by the Royal College of Surgeons in Ireland.
COLOSSUS aims to provide new and more effective ways to classify patients with a specific subtype of metastatic colorectal cancer (microsatellite stable RAS mutant metastatic colorectal cancer or MSS RAS mt mCRC) and to develop new treatment options for them. The ultimate goal is to deliver a personalised medicine approach for patients with MSS RAS mt mCRC, that is currently not available.
Visit COLOSSUS website.
